
Pidilite Share Price Falls Over 3% – What’s Driving the Drop?
Mon Apr 13 2026

Pidilite Industries — the company whose Fevicol brand has become India’s most powerful metaphor for an unbreakable bond — fell 4.8% in a session as Sika India, the Swiss construction chemicals giant, cut prices across its tile adhesive and waterproofing product lines by 12–15%. For retail investors, the Pidilite story has always been simple: Fevicol is untouchable, the brand moat is permanent, and 72x P/E is the price you pay for permanence. Today’s fall is the market’s first serious challenge to that narrative.
Click Here — Get Free Investment Predictions on Univest.
What Happened — The Full Picture
| Parameter | Detail |
| Trigger | Sika India cuts adhesive prices 12–15% across tile-fixing and construction categories |
| Sika India Revenue | Rs 1,800 Cr annually — now targeting Rs 3,000 Cr by FY28 |
| Pidilite Market Share | 67% in tile adhesive; 58% in construction chemicals |
| Pidilite Q4 FY26 Volume | Flat YoY — first zero-growth quarter in 6 years |
| Dr Fixit vs Sika | Sika targeting Pidilite’s most profitable construction chemicals segment |
| Birla Opus Parallel | Birla Opus in paints; Sika in adhesives — both attacking market leaders simultaneously |
| Madhukar Bhagat Comment | Pidilite MD: ‘Brand loyalty is our strongest moat — price alone cannot displace Fevicol’ |
Why the Market Is Selling Pidilite Industries Today
Tap to Access Best Research Pieces on Univest.
The Bull Case — Why the Sellers Might Be Wrong
What Most Investors Are Missing
Pidilite Industries Share Price: Levels, Support & 2026 Target
| Parameter | Value |
| CMP (April 2026) | Rs 2,580 |
| 52-Week High | Rs 3,400 |
| 52-Week Low | Rs 2,420 |
| Decline from Peak | 24% |
| Market Cap | Rs 1.3L Cr |
| Trailing P/E | 72x |
| 12M Analyst Target | Rs 2,900–3,200 |
| Short-Term Support | Rs 2,420–2,500 |
| Short-Term Resistance | Rs 2,750–2,900 |
| NSE Symbol | PIDILITIND |
Download the Univest iOS App or Univest Android App to track Pidilite Industries live with SEBI-registered research alerts.
The Three Scenarios Investors Are Pricing In Right Now
Key Business Segments & What to Watch
Track Pidilite Industries and sector peers live on the Univest Screener — real-time fundamentals, FII/DII flows, and analyst ratings.
What Should Pidilite Industries Shareholders Do Today?
Pidilite at Rs 2,580 — 24% below its peak — offers entry into one of India’s genuinely exceptional brands at a more reasonable price than usual. The Sika threat is real in construction chemicals but the contractor network moat is the structural defense that Sika cannot replicate with a price cut. Define your thesis: if you believe contractor loyalty is durable, Rs 2,420 (52-week low) is the accumulation level. If you need evidence that Sika is not gaining share, wait for Q1 FY27 Dr Fixit volume data.
Conclusion
Pidilite’s 4.8% fall on Sika’s price offensive is the market’s most recent test of a fundamental question: can brand loyalty and distribution beat a well-funded, technically superior competitor with deep pockets? In adhesives, Pidilite’s track record of answering ‘yes’ is 30 years long. The 52-week low of Rs 2,420 is the technical line. Q1 FY27 construction chemicals volume growth is the data point that resolves the uncertainty.
This article is for informational purposes only. Please conduct your own research and consult a SEBI-registered financial advisor before making any investment decisions.
Frequently Asked Questions
Q: Why did Pidilite share price fall today?
Pidilite fell 4.8% as Sika India announced 12–15% price cuts across tile adhesive and construction chemical categories. These are Pidilite’s highest-margin segments (Dr Fixit brand). The market priced in margin compression risk on a stock trading at 72x P/E — where any earnings headwind triggers outsized reactions.
Q: What is Sika and why is it threatening Pidilite?
Sika AG is a Swiss construction chemicals company with $11 billion in global revenue. Sika India, its Indian subsidiary, has been growing at 25%+ annually targeting Rs 3,000 crore in Indian revenue by FY28. It sells tile adhesives, waterproofing, and sealants — directly competing with Pidilite’s Dr Fixit brand in construction chemicals.
Q: Is Pidilite a buy after today’s fall?
This article does not constitute investment advice. Pidilite at Rs 2,580 offers entry into a dominant brand at 24% below its peak. The construction chemicals competitive pressure is real, but Pidilite’s 80,000+ contractor network has historically proven more durable than competitor price advantages. Consult a SEBI-registered financial advisor before investing.
Q: What is Pidilite share price target 2026?
Analyst consensus 12-month Pidilite target is Rs 2,900–3,200. The stock trades at Rs 2,580, implying 12–24% upside. The construction chemicals market share defense and Q1 FY27 volume growth are the key catalysts. These are analyst estimates, not guaranteed returns.
Q: What is Dr Fixit and what are its competitive advantages?
Dr Fixit is Pidilite’s construction chemicals brand — waterproofing, tile adhesives, repairs, and protective coatings. Dr Fixit’s competitive moat is Pidilite’s contractor network of 80,000+ certified application contractors who recommend and apply the product. This network requires years to build and cannot be replicated with a price cut.
Q: How did Pidilite respond to past competitive threats?
Pidilite’s historical playbook for competitive threats: launch new sub-brands (Roff for tile grout), deepen contractor training and certification programmes, increase trade promotions and dealer credit, and accelerate product innovation. Pidilite has not typically matched competitor prices — and has consistently retained market leadership despite not doing so.
Q: What is Pidilite’s construction chemicals market share?
Pidilite holds approximately 67% of India’s organised tile adhesive market and 58% of the construction chemicals market through Dr Fixit. The construction chemicals segment contributed 18% of FY26 revenue at approximately 24% EBITDA margin — the company’s most profitable segment.
Q: What should long-term Pidilite shareholders do?
Long-term Pidilite investors should monitor Q1 FY27 construction chemicals volume data — the first quarter that will reflect Sika’s pricing impact. Rs 2,420 is the 52-week low and technical support. If Dr Fixit volumes are flat or positive despite Sika’s price cut, the competitive threat is contained and the correction was the entry. Consult a SEBI-registered financial advisor.
Disclaimer: Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decisions.
For more stock research, visit Univest Blogs.
Why is KRBL Share Price Falling? Check Next Share Price Target
Why is Reliance Infrastructures Share Price Falling? Check Next Share Price Target
Why is Mahanagar Gas Share Price Falling? Check Next Share Price Target
Why is Happiest Minds Share Price Falling? Check Next Share Price Target
Related Posts
Balkrishna Industries Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
IIFL Finance Drops 5.9% as RBI Extends Gold Loan Business Ban — Is India Shadow Banking Giant Losing Its Golden Goose?
BALAXI PHARMACEUTICALS Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Emami Drops 3.8% as CavinKare’s Nyle Wins Coconut Oil Market Share — Is the Boroplus Empire Losing Ground in Its Own Categories?
NLC India Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

